A Long Term Safety Study of BCX7353 in Hereditary Angioedema

Clinical trial NCT03472040 · COMPLETED

Trial details

NCT number: NCT03472040
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema HAE Prophylaxis

Start date: 2018-02-16
Primary completion: 2022-04-27
Enrollment: 387

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.